Up | AC
Joint Meeting of the
Anesthetic and Life Support Drugs Advisory Committee and Drug Safety & Risk
Management Advisory Committee
November 14, 2008
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
"This version of the FDA backgrounder contains a file (5. Controlled Substance Staff Review of Abuse-Deterrent Properties of EMBEDA) that was inadvertently left out of the previous version."
FDA Briefing Material (pdf)
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily agree with the
sponsor's statements. FDA has not made a final determination about the safety
or effectiveness of the product described in this document.
Briefing Material (pdf)